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C. elegansarises entirely from a single progenitor cell, the E blastomere, whose identity
is speciﬁed by GATA type transcription factors, including END-1. In response to an inductive interaction
mediated through Wnt/MAP kinase signaling pathways, POP-1, a Lef/Tcf-type transcription factor, restricts
end-1 transcription to the posterior daughter of the mesendoderm progenitor (EMS cell), resulting in
activation of endoderm differentiation by the SKN-1 and MED-1/2 transcription factors. We puriﬁed a
factor from semi-synchronized early embryos that binds to an end-1 cis regulatory region critical for its
endoderm-speciﬁc expression. Mass spectrometry identiﬁed this protein, PLP-1, as a C. elegans orthologue
of the vertebrate pur alpha transcription factor. Expression of end-1 is attenuated in embryos depleted for
PLP-1. While removal of plp-1 activity alone does not prevent endoderm development, it strongly
enhances the loss of endoderm in mutants defective for the Wnt pathway. In contrast, loss of PLP-1
function does not synergize with mutants in the endoderm-inducing MAPK pathway. Moreover, nuclear
localization of PLP-1 during interphase requires components of the MAPK pathway, suggesting that PLP-1
is inﬂuenced by MAPK signaling. PLP-1 is transiently asymmetrically distributed during cell divisions, with
higher levels in the chromatin of the future posterior daughter of EMS and other dividing cells shortly
after mitosis compared to that in their sisters. These ﬁndings imply that PLP-1 acts as a transcriptional
activator of end-1 expression that may be modulated by MAPK signaling to promote endoderm
development.
© 2008 Elsevier Inc. All rights reserved.Introduction
Developmentally asymmetric cell division, in which the daughters
of a single cell are instructed to adopt distinct fates, is a primary
mechanism used to establish differences in cell identity during deve-
lopment (Gönczy, 2008). A striking example of an asymmetric cell
division that endows daughter cells with dramatically different
developmental properties is provided by the mesendodermal pre-
cursor, the EMS cell, in the four-cell C. elegans embryo (Maduro and
Rothman, 2002, in press). EMS divides asymmetrically to generate
two of the ﬁve embryonic somatic founder cells: E, which produces
exclusively the entire endoderm of the animal, and MS, a mesodermal
precursor (Deppe et al., 1978; Sulston et al., 1983). These two cells
follow very different developmental trajectories as is ﬁrst apparent in
transcriptional differences shortly after their birth: while E tran-
scribes genes encoding the END-1 and -3 GATA-type transcription
factors (Zhu et al., 1997, 1998; Maduro et al., 2005a), which are
together necessary and individually sufﬁcient for endoderm deve-
lopment, MS transcribes tbx-35, which encodes a T box transcriptionan).
l rights reserved.factor that activates mesodermal differentiation in this lineage
(Broitman-Maduro et al., 2005, 2006).
The EMS cell generates an endoderm precursor cell in response to
an inductive signal from its posterior neighbor, P2 (Goldstein, 1992,
1993). In the absence of this induction, E adopts an MS fate. Induction
of EMS by P2 activates Wnt and MAP kinase (MAPK) signaling
pathways (Kaletta et al., 1997; Shin et al., 1999; Rocheleau et al., 1997,
1999; Thorpe et al., 1997; Meneghini et al., 1999). These signaling
pathways regulate the activity of a Lef-1/Tcf-4-type transcription
factor called POP-1 (Lin et al., 1995). POP-1 performs a pivotal function
not only in the asymmetric division of EMS, but in many, and perhaps
most, asymmetric cell divisions throughout C. elegans development
(Lin et al., 1998; Huang et al., 2007).
In response to the endoderm-inducing signals, the abundance of
POP-1 is diminished in the nucleus and accumulates at a correspond-
ingly higher level in the cytoplasm of the E cell (Lin et al., 1995;
Maduro et al., 2002; Gay et al., 2003; Lo et al., 2004). This difference in
nuclear concentration of POP-1 is observed during many asymmetric
cell divisions throughout development of the animal: POP-1 is present
at high levels in the nucleus of the anterior daughter of an asymme-
trically dividing cell and low in its posterior sister (Maduro et al.,
2002; Lin et al., 1995; Lin et al., 1998). POP-1, along with components
Fig. 1. Detection of factors that bind the end-1 promoter. (A) A 310 bp promoter region
(schematized at top) containing the putative Lef-1 binding site CTTTGAA is sufﬁcient to
drive expression of a β-galactosidase reporter in the E lineage. Anti-β-galactosidase
antibodies stain the daughters (2E) and granddaughters (4E) of the E blastomere in
transgenic embryos expressing the reporter driven by this sequence. (B) Electropho-
retic mobility shift assays performed with extracts from developing early embryos
detect a band (arrowhead, lane 4) that is eliminated when the putative Lef-1 site is
deleted (lane 2). Small oligos containing the sequence CTTTGAA compete this shift
(compare lanes 6 and 7; competing oligos were at ∼500-fold excess). Mutant oligos
with the sequence CTATGAC at the same concentration do not compete (compare lanes
7 and 8). Presence (+) or absence (-) of extract is indicated at the top of each gel lane.
13E.S. Witze et al. / Developmental Biology 327 (2009) 12–23of the Wnt and MAPK signaling pathways, is essential for the
developmental asymmetry of these various cell divisions.
The MS cell does not receive the endoderm-inducing signal, and
unsignaled POP-1 present in the MS lineage functions as a repressor
of end-1 expression (Zhu et al., 1997; Calvo et al., 2001; Maduro et al.,
2002). Endoderm induction in the E lineage causes POP-1 to switch
from a repressor to an activator, allowing a maternally contributed
transcription factor, SKN-1 (Bowerman et al., 1992, 1993), and its
mesendoderm-determining targets, the MED-1 and –2 GATA factors
(Maduro et al., 2001), to express end-1 in E (Zhu et al., 1997; Maduro
et al., 2005b; Shetty et al., 2005). Thus, the different development
fates of the EMS daughters are speciﬁed through integration of
transcriptional activators and repressors whose activities are modu-
lated by the endoderm-inducing signals. While endoderm is dere-
pressed in MS in pop-1 mutants, mutants lacking both POP-1 and the
SKN-1→MED-1/2 pathway generally lack endoderm (Maduro et al.
2001, 2007). However, a minor fraction of such embryos continue to
express end-1 and produce endoderm, suggesting that other factors
provide a positive input into end-1 transcription.
In this study, we sought to identify additional factors that activate
end-1 transcription by biochemically isolating proteins from early
embryonic extracts that bind to essential transcriptional regulatory
elements of end-1. Because fertilization cannot be synchronized in C.
elegans, we developed methods to isolate nuclear factors from
populations of semi-synchronized early embryos. We report the
identiﬁcation of a C. elegans protein, PLP-1, that is orthologous to the
human transcription factor pur alpha, and that binds to, and activates
expression of, end-1. PLP-1 is transiently asymmetrically distributed
between the chromatin of E and MS immediately following division of
the EMS blastomere and in other cell divisions throughout early
embryogenesis, concentrating at higher levels in that of the future
posterior nucleus. Elimination of PLP-1 function from early embryos, in
combinationwithmutations inWnt, but notMAPK components, results
in a synergistic loss of endoderm, suggesting that PLP-1 may function in
the MAPK pathway. Consistent with such a possibility, we found that
MAPK components are required for PLP-1 nuclear localization. Thus,
PLP-1 activates endoderm development through transcriptional regula-
tion of end-1 expression and is regulated by MAPK signaling.
Results
Detection of a factor from early C. elegans embryos that binds to the
regulatory region of end-1
In an effort to identify transcriptional regulators that inﬂuence
end-1 expression and that may have eluded detection in genetic
screens, we devised a biochemical approach to isolate factors that
bind end-1 regulatory DNA. We chose to identify such factors bioche-
mically from embryonic extracts rather than, for example, a bacterial
expression library, because their binding might require essential post-
translational modiﬁcations not present in bacterially expressed
proteins.
Many of the regulatory factors that function during early embryo-
genesis are active only transiently; thus, biochemical studies of such
factors require isolation of large numbers of embryos at similar
developmental stages. Previous biochemical approaches to identify-
ing DNA binding factors and transcription factors present during early
C. elegans embryogenesis either used methods that did not speciﬁ-
cally involve isolation of early embryos (Lichtsteiner and Tjian, 1995)
or used embryos that were allowed to accumulate at a synchronous
stage of arrest by blocking development with ﬂuorodeoxyuridine
(Stroeher et al., 1994). The latter approach allowed the production of
large quantities of embryos that, though containing the same number
of cells, had been arrested for different lengths of time. Progress made
in mass spectrometry has made it possible to identify a protein with
as little as 100 amoles of protein and, in conjunction with sequencedgenomes, these factors can be unambiguously identiﬁed from extracts
obtained from much smaller quantities of early embryos than was
possible in the past. Indeed, we found that we can readily obtain
sufﬁcient quantities of semi-synchronized developing early embryos
to allow identiﬁcation of puriﬁed factors by mass spectrometry (see
Materials and methods).
Factors that activate end-1 expression are expected to function at
around the 8-cell stage, shortly before it is ﬁrst expressed (Zhu et al.,
1997). We prepared nuclear extracts from embryo populations in
which a large fraction of the embryos were at that stage of deve-
lopment at the time of harvesting. We performed electrophoretic
mobility shift assays with these extracts and a portion of the end-1
promoter. As the target DNA sequence, we focused on a 310 bp
segment upstream of the end-1 coding sequence that is sufﬁcient to
direct E-speciﬁc expression of end-1 (Fig. 1A). Among the potential
transcription factor binding sites in this region is one that matches the
consensus for Lef-1, the orthologue of POP-1 (Love et al., 1995).
Fig. 2. Puriﬁcation and identiﬁcation of the C. elegans pur alpha transcription factor, PLP-1. (A) Fractions from the DNA afﬁnity column were assayed for binding activity to the end-1
probe. The peak DNA binding activity eluted from the column at ∼750 mM NaCl (lanes 6 and 7). (B) Antibodies against a PLP-1-speciﬁc peptide recognize the factor in the nuclear
extract that binds the Lef-1 site, as evidenced by a supershift (asterisk). Lane 1, no extract, lane 2, extract plus preimmune serum, lane 3, extract plus PLP-1 antibody. The arrowhead
indicates the position of the normal shift that is dependent on the critical end-1 regulatory sequences. The lower band that is not supershifted is seen only variably. (C) The 100 bp
region of the end-1 promoter that is bound by PLP-1 is resistant to the singlestranded exonuclease Exo I. Lanes 1 and 3, no extract, Lanes 2 and 4 extract included. Reactions contained
either added Exo I buffer alone (Lanes 1 and 2) or buffer plus Exo I (Lanes 3 and 4). (D) Digestion of the active fractions with trypsin followed bymass spectrometric analysis identiﬁed
ten peptides that match the C. elegans orthologue (PLP-1) of the vertebrate transcription factor pur alpha (underlined on the PLP-1 sequence). (E) Alignment of predicted C. elegans
pur alpha orthologues (PLP-1 and PLP-2) with human pur alpha. Identical residues are shown in black boxes, similar residues in grey boxes. PLP-1 and PLP-2 are encoded by separate
genes. The line above the sequences indicates the known pur alpha DNA binding domain.
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310 bp region abolishes expression of an end-1 reporter construct,
demonstrating its essential requirement in activation of end-1
(Maduro et al, 2005b). We found that a factor in the early embryo
extracts showed signiﬁcant binding to a 100 bp segment containing
this site (Fig. 1B). Moreover, the site that is essential for expression of
end-1 is also required for normal binding of the factor: deletion of the
site from the probe eliminated binding activity (Fig. 1B, lane 2). Com-
petition experiments conﬁrmed the speciﬁcity of the binding of this
factor around the essential site: an oligonucleotide containing the
consensus Lef-1 binding sequence CTTTGAA, which is present at the
site, is able to compete the shift, while a mutant oligonucleotide
containing two base changes in the sequence (CTATGAC) is unable to
compete effectively (Fig. 1B lanes 7 and 8). (The relatively weak com-
petition by this oligonucleotide may reﬂect that this small oligonu-
cleotide is a less natural substrate for binding than a larger DNA
fragment.) Thus, nuclear extracts of early embryos contain a factor
that speciﬁcally recognizes end-1 regulatory DNA, including a site that
is essential for activation of end-1 expression in early embryos.
Mass spectrometric identiﬁcation of the end-1-binding factor: A
C. elegans orthologue of the mammalian transcription factor pur alpha
To identify the factor that binds to the essential element in the
end-1 promoter, we puriﬁed it by afﬁnity chromatography. A 50 bp
fragment containing the essential element was labeled with biotin
and incubated with nuclear extract. The reaction mixture was passed
over a streptavidin column and bound proteins eluted off the column
with a stepwise NaCl gradient. Each fraction from the column was
assayed by the gel shift assay and signiﬁcant enrichment of the DNA
binding activity was observed in the 750 mM NaCl eluate (Fig. 2A,
compare lane 6 to lane 1).
While these fractions would be expected to contain a mixture of
proteins, ourmass spectrometric procedures are capable of resolving a
large number of polypeptides in a mixture. Whole fractions were
digested with trypsin and analyzed by electrospray mass spectro-
metry (see Materials and methods). The resulting peptide maps were
used to search the C. elegans sequence database to identify the
corresponding genes. The puriﬁcation and mass spectrometry were
performed several times during optimization of the procedures, and
as many as 19 proteins were identiﬁed in fractions containing binding
activity, most of which were represented by peptides covering only 1–
10% of the predicted protein sequence. Many of the identiﬁed proteins
were obvious contaminants such as the vitellogenins, which are
highly abundant in early embryos. The protein with the highest
percentage of peptide coverage (10 peptides, 45% coverage) was a
homologue of the vertebrate transcription factor pur alpha (Figs. 2D
and E). Since this protein was also found the most consistently in the
peak activity fractions, it was the best candidate for the factor that
speciﬁcally binds the end-1 regulatory region, as conﬁrmed in
subsequent experiments (see below). We named this protein PLP-1
(Pur Alpha Like protein-1).
To assess whether the factor that binds to the end-1 regulatory
region is PLP-1, we prepared antibodies against PLP-1 and performed
supershift experiments. We found that two independent PLP-1
antibodies made against two different peptides, but not preimmune
serum, completely supershifted this band in the mobility shift assays
(Fig. 2B), conﬁrming that PLP-1 is the relevant protein causing the
shift.
PLP-1 shares overall 32% identity and 48% similarity with human
pur alpha (Fig. 2E). It contains a segment corresponding to the known
DNA binding domain of the human protein, but lacks the glycine-rich
region at the N-terminus (Fig. 2E). A second pur alpha-encoding gene
present in the C. elegans genome shares 88% identity and 93%
similarity with PLP-1, but is 96 amino acids shorter than PLP-1 and
lacks part of the DNA binding domain. None of the peptides weidentiﬁed bymass spectrometry were speciﬁc to this second pur alpha
homologue.
Mammalian pur alpha preferentially binds to purine-rich, single-
stranded DNA (Bergemann and Johnson, 1992). We found that PLP-1
also binds strongly to a 25 nt purine-rich strand spanning the
essential Lef-1 site but not to the complementary pyrimidine-rich
single-stranded probe (not shown). The ability of PLP-1 to bind
single-stranded DNA raised the possibility that the mobility shift
originally observed with the double-stranded probe was caused by
contaminating single-stranded DNA. To address this possibility, we
repeated the experiments following incubation of the end-1
promoter probe with Exo I, a single-strand-speciﬁc exonuclease.
We found that Exo I had no effect on the DNA binding activity of
PLP-1 (Fig. 2C), demonstrating that PLP-1 binds to double-stranded
DNA from the end-1 promoter.
Much of the existing information on pur alpha has come from
in vitro and cell culture systems. Pur alpha was ﬁrst identiﬁed by
its ability to bind to the promoter of the c-myc gene; it was also
shown to increase transcription of the myelin basic protein gene both
in vitro and in vivo (Bergemann and Johnson, 1992; Haas et al., 1993,
1995). Stimulation of cultured cells with phorbol esters results in
increased pur alpha protein and RNA levels and DNA binding activity
(Shelley et al., 2002). Co-expression studies revealed that pur alpha
causes a four-fold enhancement of CD11 gene expression and repres-
ses transcription of the beta integrin gene (Shelley et al., 2001). A
mouse knockout revealed a role for pur alpha in postnatal brain
development and cell proliferation (Khalili et al., 2003). Although
these studies have implicated pur alpha in regulation of transcription,
only limited information regarding its roles in regulating develop-
ment has been obtained. For example, it has been shown to repress
the gene encoding GATA2 in the zebraﬁsh nervous system (Penberthy
et al., 2004) and has been implicated in neurodegeneration in
Drosophila (Jin et al., 2007). In this study, we have focused on the
role of PLP-1 in end-1 expression and endoderm development. More
detailed analysis of the interaction of PLP-1 with end-1 regulatory
DNA will be described elsewhere (E. Witze and J. Rothman, in prep.).
plp-1 is required for normal end-1 expression levels
Given its ability to bind to end-1 regulatory sequences, we sought
to determine whether PLP-1 might be important for end-1 expres-
sion. As there are two pur alpha homologues in C. elegans whose
coding regions share very strong sequence identity, we designed a
double-stranded RNA (dsRNA) that recognizes sequences present
only in plp-1 (see Materials and methods). As described below,
immunoreactive PLP-1 localizes primarily to nuclei throughout
embryos (Fig. 3); injection of this plp-1-speciﬁc dsRNA into adults
effectively reduced or abolished immunoreactive PLP-1 from their
progeny embryos (Figs. 3A–D).
Expression of end-1 was monitored using an end-1 reporter
containing 1.5 kb of upstream DNA and the ﬁrst exon of the gene.
This reporter shows high levels of expression speciﬁcally in the E
lineage (e.g., Figs. 3E and G). We found that, while nearly all untreated
embryos express this reporter at high levels, approximately half (49%;
n=73) of the plp-1(RNAi) embryos that were positive for a control
marker (the immunoreactive germline P granules; Kawasaki et al.,
1998) showed substantially reduced, or abolished expression of end-1
(e.g., Figs. 3F and H; quantiﬁcation in Fig. 3M). In contrast, plp-1(RNAi)
had no detectable effect on the expression of either med-1, which
regulates, and is expressed immediately prior to, the onset of end-1
expression, or of the ectodermal transcription factor LIN-26, which is
expressedmuch later in embryogenesis (not shown). Thus, PLP-1 does
not appear to be generally required for efﬁcient zygotic transcription.
The ability of plp-1(RNAi) embryos to express end-1 (albeit at
attenuated levels) is likely to be attributable to the continued presence
of the MED-1/2 factors, which activate end-1 and are required for high
Fig. 3. RNAi of plp-1 reduces end-1 expression. (A–D) PLP-1 staining is diminished or eliminated by RNAi of plp-1 (B and D; compare with wild type, panels A and C). Antibody to PGL-
1 (Kawasaki et al., 1998), a component of the germline-speciﬁc P-granules, was used as a positive control for permeabilization (arrowheads). (E–H) Anti-β-galactosidase antibody
staining of the same embryos expressing an end-1 reporter. plp-1(RNAi) embryos show reduced expression of the reporter at the 2E stage (F) and 4E stage (H) compared to wild type
(E and G). (I–L) The same embryos as in panels A–H stained with DAPI to reveal nuclei. (M) Distribution of embryos expressing end-1 at levels that appear normal (wt), strongly
reduced, and undetectable (off). plp-1(RNAi) embryos that that were positive for P granule staining and that showed loss of PLP-1 immunostaining (to compensate for impenetrant
reduction of plp-1) were scored for end-1 expression. The results were summed over eight experiments in total (143 wild-type control embryos and 138 plp-1(RNAi) embryos). Error
bars indicate standard error of the mean.
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2005). We found that RNAi speciﬁcally directed against plp-2 showed
no obvious effect and did not enhance the phenotypes we observed
for plp-1(RNAi); hence, PLP-2 does not appear to synergize with PLP-1
in regulating end-1 or endoderm formation (see below).
PLP-1 synergizes with the Wnt but not MAPK pathway to regulate
endoderm speciﬁcation
While RNAi of plp-1 results in diminished end-1 expression and
embryonic lethality (50–100% in microinjection experiments), we
found that plp-1(RNAi) embryos only rarely lack endoderm (Figs.
4A and B; Table 1). Thus, while PLP-1 is required for normal end-1
expression, it presumably acts in concert with other regulators of
end-1. Several independent regulatory systems, including Wnt
and MAPK signaling, are known to be required for formation of the
C. elegans endoderm (Shin et al., 1999; Rocheleau et al., 1997, 1999;
Thorpe et al., 1997; Meneghini et al., 1999). Elimination of any one ofthese regulatory inputs results in impenetrant loss of endoderm,
while loss of multiple inputs leads to synergistic phenotypes.
We investigated whether PLP-1 functions in concert with other
regulatory processes by analyzing genetic interactions between
them. Depletion of PLP-1 did not signiﬁcantly change the
penetrance of a mutant lacking MOM-4 (MAPKKK) function: 42%
(n=130) of mom-4(or39); plp-1(RNAi) embryos lacked endoderm,
essentially indistinguishable from the mom-4(or39) single mutant
embryos (40% without endoderm; n=151) (Table 1). In contrast,
when combined with mutants defective in the endoderm-inducing
Wnt pathway, RNAi of plp-1 results in synergistic loss of endoderm
(Fig. 4; Table 1). The magnitude of this synergy was particularly
evident in double mutants with mom-5(or57), which carries a
mutation in the MOM-5 Wnt receptor (Thorpe et al., 1997;
Rocheleau et al., 1997): while, as with plp-1(RNAi) mutants, only a
very small fraction (3%) of mom-5(or57) mutants lack endoderm,
more than one-third of the mom-5 (or57); plp-1(RNAi) embryos do
not make differentiated gut (Table 1). Synergy was also seen with
Fig. 4. Synergy of PLP-1 and Wnt signaling functions. (A) plp-1(RNAi) embryos that lack immunoreactive PLP-1 (see Fig. 3) generally produce differentiated gut, detected by the
presence of birefringent gut granules by polarized light, as seen in ﬁelds of embryos shown at lowmagniﬁcation. (B) Higher magniﬁcation of ﬁeld boxed in A under Nomarski optics.
(C) Arrested mom-2(or42) mutant embryos. ∼40% produce differentiated gut. (D) Arrested mom-2 (or42); plp-1(RNAi) double mutant embryos, only 6% of which produce
differentiated gut. (E) Arrested mom-2; pop-1(RNAi); unc-22(RNAi) embryos, nearly all of which produce gut. unc-22(RNAi) was used as a negative control for the plp-1(RNAi)
experiments. (F) Arrested mom-2; pop-1(RNAi); plp-1(RNAi) embryos. The synergistic loss of endoderm is independent of repression by POP-1.
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Wnt ligand: mom-2(or42); plp-1(RNAi) embryos almost never make
endoderm, whereas approximately one-third of mom-2 single
mutants do (Table 1).
The loss of endoderm in Wnt pathway mutants results from the
failure to convert POP-1 from its endoderm-repressive to endoderm-
activating form (Maduro et al., 2005b; Shetty et al., 2005): in the
absence of Wnt signaling, POP-1 acts as a repressor of the end genes in
the E cell, just as it normally does in MS. Removal of POP-1 function
restores endoderm in embryos mutant for the Wnt pathway (ThorpeTable 1
Genetic interaction of PLP-1 with Wnt and MAPK mutants
Genotype % Lacking endoderm (n)
plp-1(RNAi) 3 (330)
mom-4(or39); unc-22(RNAi) 41 (151)
mom-4(or39); plp-1(RNAi) 42 (130)
mom-5(or57); unc-22(RNAi) 3 (79)
mom-5(or57); plp-1(RNAi) 35 (88)
mom-2(or42); unc-22(RNAi) 66 (302)
mom-2(or42); plp-1(RNAi) 96 (265)
mom-2(or42);plp-1(RNAi); pop-1(RNAi) 42 (115)
mom-2(or42); unc-22(RNAi); pop-1(RNAi) 0 (85)
pop-1(zu189); plp-1(RNAi) 0 (286)
Percentage of arrested embryos lacking endoderm was determined for each of the
indicated genotypes. unc-22, which performs no relevant role in endoderm
speciﬁcation, was used as a negative control for the plp-1(RNAi) experiments. The
data were taken from representative experiments repeated at least twice.et al., 1997; Rocheleau et al., 1997). Thus, the increased penetrance of
the mom; plp-1(RNAi) double mutant condition could be attributable
to an increase in POP-1 repressive activity rather than a direct positive
role for PLP-1 in end-1 transcription. To test this possibility, we
examined the effect of removing pop-1 activity in the mom-2(or42);
plp-1(RNAi) double mutant. While this experiment resulted in some
increase in the fraction of embryos making endoderm, as is as expec-
ted from derepression of endoderm in MS, 42% (n=115) of the
embryos still lacked endoderm (Fig. 4F and Table 1). This result
demonstrates that the increased loss of endoderm in themom-2; plp-1
(RNAi) double mutant is largely independent of POP-1 repression, and
implies that PLP-1 functions in parallel with the Wnt pathway to
activate endoderm development.
The synergy seen between plp-1(RNAi) and the Wnt, but not
MAPK, pathway mutants suggests that PLP-1 acts in parallel to the
Wnt pathway and raises the possibility that it might function in the
MAPK pathway.
PLP-1 is asymmetrically localized during cell division
The foregoing results suggest that PLP-1 modulates gene expres-
sion in response to signaling events that regulate a developmentally
asymmetric cell division. We analyzed localization of PLP-1 protein to
assess whether it might be inﬂuenced by events occurring during
division of EMS. Immunoreactive PLP-1 localizes to the nuclei of all
blastomeres beginning by the two-cell stage of embryogenesis (Figs. 3
and 5), implying that PLP-1 is a maternally encoded transcription
Fig. 5. Asymmetric distribution of PLP-1 protein in early embryos. PLP-1 staining was analyzed in 10 separate experiments and asymmetries described observed in a total of 24
embryos (see text). (A) PLP-1 is asymmetrically distributed during the ﬁrst cell divisionwith higher levels inwhat will become the nucleus of the posterior (P1) cell (arrow). (B) At the
4 to 6 cell transition, immunoreactive PLP-1 is asymmetrically distributed in the left/right AB granddaughters (connected by lines). (C) PLP-1 is asymmetric between the AB great
granddaughters (connected by lines) with higher levels in posterior blastomeres and lower in the anterior. Germline speciﬁc P-granules also contain PLP-1 (arrowhead). (D) During
the following division PLP-1 is asymmetric in the dividing EMS blastomere, with higher levels in the chromatin of the future E (arrow) than in the future MS nucleus (arrowhead).
Note that the AB granddaughters show symmetric PLP-1 staining later in the cell cycle. (E–H) DAPI staining of the corresponding embryos shown in the left panels.
18 E.S. Witze et al. / Developmental Biology 327 (2009) 12–23factor. It is also present in the germline-speciﬁc P granules of early
embryos (Fig. 5C, arrowhead). The same pattern was seen with two
separate antibodies raised against distinct PLP-1 peptides, and both
nuclear and P granule expression was largely eliminated in plp-1
(RNAi) embryos (Fig. 3), conﬁrming their speciﬁcity.
Consistent with a role in regulating gene expression in the E cell,
we found that PLP-1 is transiently asymmetrically localized during
telophase of the dividing EMS cell (observed in 12 embryos at the
correct stage), with higher levels of the protein in the chromatin of
the future E cell nucleus and low or undetectable levels in that of MS
(Fig. 5). A similar transient asymmetry in PLP-1 levels was observed
at many divisions throughout early development, starting at cleavage
of the zygote, with higher levels seen in the cytoplasm and forming
nucleus of the posterior daughter, P1 (observed in 5 embryos; e.g.,
Figs. 5A and B). The anteroposterior asymmetry in PLP-1 was alsoobserved in the AB lineage during the division of the AB grand-
daughters (observed in 7 embryos): for example, PLP-1 is higher in
the chromatin of the posterior daughter ABalp than that of its ante-
rior sister ABala (Fig. 5C). In all cases, the asymmetry was observed
only during telophase and at the time that nuclei were reassembling
after cell division; the staining was symmetric at all other times. This
asymmetry was also seen during the preceding division in the AB
lineage (Fig. 5B). This was unexpected, as these are developmentally
symmetric left/right divisions that produces initially equivalent
daughter cells (Wood, 1991); however, these divisions do show a
clear anteroposterior bias and, again, PLP-1 was always seen at higher
levels in the forming nuclei of the posterior daughters.
Asymmetry of protein localization is a recurring theme during
asymmetric cell division. For example, POP-1 is present at higher
levels in anterior daughter nuclei of such divisions (Lin et al., 1995,
19E.S. Witze et al. / Developmental Biology 327 (2009) 12–231998; Maduro et al., 2002) and a LIT-1::GFP fusion protein shows a
reciprocal localization, being at higher levels in the posterior
daughter cells than in their sisters (Lo et al., 2004). The asymmetric
distribution of PLP-1 suggests that it may be inﬂuenced by the
machinery that establishes anterior/posterior asymmetry during cell
divisions.
Nuclear localization of PLP-1 requires MAPK components
The genetic evidence suggesting that PLP-1 might function in the
MAPK pathway led us to examine whether its localization is affected
by MAPK components. We found that, while PLP-1 is strongly loca-
lized to nuclei in interphase cells of wild-type embryos throughout
early embryogenesis, it is at much lower levels in nuclei and higher in
the cytoplasm in mutants defective in the LIT-1 MAPK (both lit-1
(RNAi) and lit-1(t1512)) (Fig. 6). This effect on PLP-1 nuclear locali-Fig. 6. PLP-1 nuclear localization requires lit-1 andmom-4 function. (A–D) PLP-1 staining inW
wildtype (Fig. 3),mom-2, andmom-4mutant embryos (A and B). Cytoplasmic levels of PLP-1 a
(RNAi); mom-4 double mutants (D). (E–H) Staining with MPM2 control, showing very little ozation is dramatically enhanced in a double mutant that is also defec-
tive in the MOM-4 kinase, which functions upstream of LIT-1: PLP-1
accumulates in the cytoplasm and does not concentrate to appreci-
able levels in the nucleus of lit-1(RNAi); mom-4(or39) double mutants
(Fig. 6D). This result does not reﬂect a general effect of MAPK
components on localization of nuclear factors: for example, the
nuclear MPM2 antigen (Figs. 6E–H) and POP-1 (Shin et al, 1999), are
properly localized in lit-1; mom-2 double mutants. These ﬁndings
suggest that MAPK components are required for efﬁcient nuclear
translocation or retention of PLP-1.
Discussion
The simple lineage that generates the C. elegans endoderm is
speciﬁed by a complex intersection of signaling systems and tran-
scriptional cascades (Maduro and Rothman, 2002, in press). Whilent andMA PKmutants. PLP-1 is at highe r levels in the nucleus than in the cytoplasm in
re increased in lit-1(RNAi) embryos (C). PLP-1 is largely excluded from the nucleus in lit-1
r no effect on nuclear localization of the nuclear protein recognized by this antibody.
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regulatory events, components that modulate gene expression
associated with, but not absolutely essential for, endoderm formation
would be overlooked in screens for mutants with striking endoderm
phenotypes, although elimination of such components might cause
synergistic effects with loss of other regulatory inputs. We have taken
a biochemical approach to identify a C. elegans orthologue of the
vertebrate pur alpha factor, PLP-1, that is required for efﬁcient
expression of end-1 and for endoderm development when the endo-
derm-inducing Wnt signaling pathway is defective.
Biochemical puriﬁcation methods, most notably with sea urchins
from which massive quantities of synchronized embryos can be
obtained (e.g., Calzone et al., 1991), have made it possible to identify
many of the transcription factors that regulate cell identity in
developing embryos (e.g., Davidson et al., 2002). A similar approach
with C. elegans is more difﬁcult, as it is not possible to fertilize large
numbers of embryos synchronously and its embryos are vastly
smaller. We have developed methods for isolating extracts from
semi-synchronized embryos and have exploited more sensitive and
accurate mass spectrometry methods to overcome the biochemical
shortcomings of C. elegans. This approach allowed us to identify
regulatory factors from small quantities of actively developing
embryos. In addition, individual proteins can be identiﬁed in complex
mixtures by these methods and we were able to resolve PLP-1 from
other proteins in partially puriﬁed preparations. Subsequent studies
with PLP-1 antibodies conﬁrmed that it is the relevant end-1-binding
protein.
It is conceivable that PLP-1 activity is modulated by endoderm-
inducing signals in the E lineage to provide a positive input into end-1
expression. Several lines of evidence suggest that PLP-1 might be
inﬂuenced by the endoderm-inducing MAPK pathway. First, con-
sistent with its binding activity, PLP-1 is required to activate
expression of end-1, which is also activated by the MAPK signaling
pathway. Second, while PLP-1 functions synergistically with the Wnt
pathway to control end-1 gene expression and endoderm formation,
it does not synergize with MAPK pathway components, genetic
evidence that it may operate in this pathway. Further, the MAPK
components LIT-1 and MOM-4, are required for efﬁcient nuclear
localization of PLP-1. In the absence of MAPK signaling, PLP-1 accu-
mulates in the cytoplasm, where it presumably would be unable to
activate end-1 transcription. The activity of many transcription
factors is regulated at the level of their nucleocytoplasmic localiza-
tion (e.g. Maduro et al., 2002). PLP-1 might similarly be regulated by
MAPK-dependent nuclear localization and/or activation as a tran-
scription factor.
The MAPK pathway functions recursively with the Wnt pathway
to control asymmetric cell division throughout C. elegans develop-
ment (Kaletta et al., 1997; Shin et al., 1999; Rocheleau et al., 1997,
1999; Thorpe et al., 1997; Meneghini et al., 1999). The reiterative use
of these signaling systems to generate differences between daughter
cells generated by anteroposterior divisions is associated with
asymmetric nucleocytoplasmic distribution of their effector, POP-1.
POP-1 is excluded from the nucleus after phosphorylation by LIT-1
kinase and becomes localized to the nucleus in response to
acetylation by the p300/CBP acetyl transferase (Gay et al., 2003).
Immunoreactive PLP-1 is strongly nuclear in early wild type embryos,
but the protein is almost completely cytoplasmic in lit-1; mom-4
double mutants. The cytoplasmic localization of PLP-1 in the absence
of MAPK signaling is reciprocal to that seen for POP-1, when it func-
tions as a repressor of end-1 (e.g., Lo et al., 2004). Thus, MAPK
signaling system might help to coordinate the differential activity of
these two transcription factors during asymmetric cell divisions. We
have found that POP-1 can compete with PLP-1 for binding to the
fragment containing the Lef-1 site (not shown), though the signi-
ﬁcance of this competition in vivo is not clear. In vitro studies to
assess physical interaction between PLP-1 and POP-1 in co-precipita-tion experiments did not reveal evidence for interaction between the
two proteins (not shown).
PLP-1 is asymmetrically localized to the posterior chromatin
during the division of EMS. It is conceivable that the asymmetry we
observed in this and other cell divisions might reﬂect slight,
reproducible differences in cell cycle timing of the daughters; how-
ever, no such difference in timing of formation of the nascent nuclei
following cell division has been described. During early embryogen-
esis in the C. elegans embryo, at the time that E and MS are born, there
are no G1 or G2 phases, implying that zygotic transcriptionmust occur
during S phase and/or mitosis (Edgar and McGhee, 1988). The
presence of PLP-1 in the newly forming E nucleus might allow end-1
to be poised for activation following the birth of the E cell. This very
early and transient difference in PLP-1 levels may reveal an additional
layer of transcriptional regulation that facilitates the rapid and res-
tricted E-speciﬁc expression of the end genes and thereby the
endoderm fate following asymmetric cell division.
Several observations suggest that the DNA binding activity of PLP-1
may be regulated by phosphorylation (E.W. and J.R., unpublished
results). PLP-1 contains a putative proline-directed kinase site that is
required for phosphorylation in vitro by a puriﬁed MAPK. In addition,
we found that PLP-1 becomes phosphorylated when incubated with
embryo extract, demonstrating the presence of a PLP-1 kinase in early
embryos. Treatment of embryonic extracts with lambda phosphatase
eliminates binding of PLP-1 to end-1. However, evidence that PLP-1
phosphorylation by the MAPK pathway might be responsible for
regulating its transcriptional activity in vivo will require further
investigation.
Materials and methods
Nuclear extract preparation
To obtain large numbers of early embryos for nuclear extract
preparation, each of 30 150 mm peptone-enriched plates were
seeded with ∼80,000 starved L1 larvae, which were allowed to
develop until shortly after they were visibly gravid. Hermaphrodites
were harvested when they contained primarily embryos classiﬁed as
“early” (N90% with 100 cells or less based on microscopic analysis).
We found that this culturing method, involving growth on peptone-
enriched solid medium rather than liquid culture, produced large
quantities of early embryos speciﬁcally, as hermaphrodites tend to
accumulate later embryos when grown in liquid. At the stages that
they were harvested, nearly all of these embryos express end-1.
Adults were washed off and allowed to settle on ice. The supernatant
was removed and alkaline bleach was added to the worms, which
were incubated on ice until no carcasses remained. The nuclear
extract protocol was modiﬁed for C. elegans embryos from an existing
protocol for cell culture (Ausubel et al., 2004). Embryos were washed
three times in M9 buffer at 0 °C and resuspended in 1 ml of hypotonic
buffer (10 mM HEPES, 1.5 mM MgCl2, 10 mM KCl, 0.5 mM DTT, 1 mM
PMSF, 10 μM E64 (Sigma), 0.2 mM EDTA), centrifuged, and the pellet
resuspended in hypotonic buffer. Embryos were then homogenized
with a Dounce homogenizer (pestle B) until they were all disrupted.
The homogenate was immediately centrifuged for 10 min at 3000 ×g
at 4 °C. The supernatant was removed and the pelleted nuclei
resuspended in one packed nuclear volume (pnv) of low salt buffer
(20 mM HEPES, 25% glycerol, 0.2 M KCl, 1.5 mM MgCl2, 0.2 mM EDTA,
0.5 mM DTT, 1 mM PMSF, 10 μM E64). An equal volume of high salt
buffer (same as the low salt buffer with 1.2 M KCl) was added slowly
while stirring. The pellet was thoroughly resuspended and the nuclei
were incubated on ice for 1 h and then pelleted at 16,000 ×g for
30 min. The supernatant (nuclear extract) was collected and
centrifuged again for 30 min at 16,000 ×g. The nuclear extract was
transferred to dialysis tubing and dialyzed for 2 h in 50 volumes of
dialysis buffer (20 mM HEPES, 20% glycerol, 100 mM KCl, 0.2 mM
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was then centrifuged at 16,000×g for 30 min, aliquotted, frozen in
liquid nitrogen, and stored at -80 °C.
Electrophoretic mobility shift assay
Typical gel shift reactions contained 50 fmoles of 32P-end labeled
probe, 10 μg of crude nuclear extract, 1 μg of poly dIdC:dIdC non-
speciﬁc competitor and 1 μl of 10X binding buffer (50% glycerol,
100 mM HEPES, pH 7.6, 10 mM EDTA, 600 mM KCl, and 10 mM DTT)
in a ﬁnal volume of 10 μl. Optimum amounts of probe, extract, and
non-speciﬁc competitor were determined by preliminary titrations.
Binding reactions were incubated for 15 min at room temperature,
loaded onto a non-denaturing, 1.5 mm thick, 5% polyacrylamide gel
with 1X TBE, and electrophoresed at 4 °C. Gels were dried and
exposed to ﬁlm. For exonuclease treatment, probes were incubated
for 2 h at 37 °C with 10 U of ExoI (New England Biolabs) in a 10 μl
reaction. Activity was conﬁrmed by digesting labeled single-
stranded probe.
Afﬁnity puriﬁcation of nuclear extract
100 pmoles of target DNA was biotinylated using terminal
transferase (TdT) (New England Biolabs) to add biotin-ddUTP to the
3′ hydroxyl group of the DNA oligo. 100 pmole of oligo were
incubated with 10 μl of 10× buffer, 20 μl of 2.5 mM CoCl2, 2 μl 1 nmol
biotin-16-ddUTP (Boehringer Mannheim) and 40 U TdT, in a 100 μl
volume for 1 h at 37 °C. The labeled oligo was precipitated, resus-
pended in water, and used immediately. 100 pmoles of biotin-labeled
oligo was incubated with 250 μl of crude extract (10 mg/ml) for 1 h at
4 °C. The binding reaction was loaded onto a column of streptavidin
beads (Sigma) and the ﬂow-through passed over the column a second
time. The column was washed with 3 bed volumes of 1X binding
buffer and then eluted with 50 μl of elution buffer (5% glycerol,
20 mM Tris pH 8.5, 2 mM EDTA, 1 mM DTT with stepwise increases of
NaCl from 90 mM to 1.5 M). 50 μl fractions were collected and
assayed by gel shift analysis.
In-solution digestion of proteins
Approximately 130 pmol of total protein from each DNA-afﬁnity
column fraction was equilibrated in 30 μL of 100 mM Tris buffer, pH
8.8. Modiﬁed trypsin (Promega, Madison, WI) was added in a ratio of
1:25 (enzyme:protein) and the digest was incubated at 37 °C for 1 h
and then incubated at room temperature for approximately 18 h. The
enzymatic digestion was stopped by adding 2 μl of concentrated
glacial acetic acid (HOAc, Sigma, St. Louis, MO, 99.99% pure). The
sample was then stored at −36 °C until mass spectrometric analysis
was performed.
Electrospray ionization mass spectrometry
The entire sample volume from each proteolytically digested DNA-
afﬁnity column fraction was loaded onto a pre-column via helium
bomb at ∼500psi. After sample loading, the pre-column was washed
with 0.1% HOAc in NANOpure (Barnstead, Dubuque, IA) water for
approximately 10 min to desalt the sample. The pre-column was then
Teﬂon-connected to the analytical column and interfaced to a
modiﬁed LCQ quadrupole ion trap mass spectrometer (ThermoElec-
tron Corporation, San Jose, CA).
The analytical column was connected to the HPLC line with ESI
voltage (1.5–1.8 kV) being applied pre-column at a stainless steel
union on the waste line. Tryptic peptides from the DNA-afﬁnity
column were eluted into the mass spectrometer using the follo-
wing gradient: 0–15% B (0–4 min), 15–50%B (4–15 min), 50–100%B
(25–28 min), 100% B (28–30 min), 100–0%B (30–32 min), 0%(32–44 min) where solvents A and B were 0.1 M HOAc in NANOpure
water and 0.1 M HOAc in 70% acetonitrile (MeCN, Mallinkrodt, Paris,
KY), respectively. The emitter tip was positioned about 1–2 mm in
front of the oriﬁce of the heated metal capillary prior to data
acquisition. The ﬂow rate of analyte solution out of the column was
∼40 nl/min.
Data ﬁltering and database searching
ProteoFarm (Hunt lab: Dr. Robert Settlage and Galvin Hsiu) was
used as an interface between the rawmass spectrometric information
and a database searching program, SEQUEST. Poor quality MS/MS
spectra can be ﬁltered out prior to database searching.
The RAW data ﬁle format (MS/MS spectra) created by the LCQ
software was converted to DTA ﬁle format. All poor quality spectra
were deleted based on the following parameters: minimum number
of total fragment ions is 50, maximum of 10 ions present at above 30%
abundance of the base peak (more than this is uncharacteristic of
interpretable peptide MS/MS spectra), and a minimum total ion
current of at least 15,000 ion counts. After deleting poor quality
spectra, the charge states of peptides are assigned to the spectra.
All mass spectrometric data from the biotin-DNA afﬁnity column
fractions were searched against the C. elegans database that is main-
tained by the National Center for Biotechnology Information (NCBI,
http://www.ncbi.nlm.nih.gov) using SEQUEST. The entire peptide
mass in the database had to be within a 3.0 Da window of the
monoisotopic experimental peptide mass to be considered a match
and the fragment ions had to be within 0.35 Da to be considered a
match with the average experimental fragment ions masses.
Antibody production
Synthetic peptides containing the sequences CLIDEPSTGEHAPKES
(peptide #51), and CGSVERGTKRAEDSLA (peptide #52) were con-
jugated to maleimide-activated KLH (Pierce). The injection of rabbits,
test bleeds, production bleeds, and exsanguinationwere performed by
Cocalico Biologicals Inc. The conjugated peptides were injected
separately into New Zealand White rabbits.
Antibody puriﬁcation
GST::PLP-1 was isolated from 1 l of culture and bound to a 1–2 ml
bed volume of glutathione agarose beads. The bound protein was
washed thoroughly in GST wash buffer (50 mM Tris pH 7.6,
150 mM NaCl) and 1 bed volume of 0.2% glutaraldehyde in PBS was
added to the beads. The beads were incubated at room temperature
for 10–20 min. The beads were centrifuged and washed three times
in 10 ml volumes of PBS and incubated in PBS overnight at 4 °C.
10% BSA in 1× PBS was added to the beads and incubated at room
temperature for 0.5 h. The beads were centrifuged and washed
twice in 10 ml volumes of PBS. 2 ml of serum was added to the
beads and incubated with gentle agitation at 4 °C overnight. The
beads were pelleted and washed twice in 10 ml of GST wash buffer.
The beads were resuspended in one bed volume of Gentle Elution
Buffer (Pierce) and incubated at room temperature for 10 min. The
supernatant was removed and the antibodies concentrated with
30 kDa MW cut-off ultraﬁlter (Millipore). The elution buffer was
exchanged with GST wash buffer.
Immunostaining
Embryos were ﬁxed for 15 min in 4% paraformaldehyde, 0.1%
glutaraldehyde in PBS and immersed in dimethyl formamide at −20 °C
for 20 min. The slide was washed in PBST and blocked with 5% goat
serum. It was then incubated with PLP-1 antibody diluted 1:50 in 5%
goat serum in PBS overnight at 4 °C, washed in PBST and goat anti-
22 E.S. Witze et al. / Developmental Biology 327 (2009) 12–23rabbit secondary antibody (1:500), and incubated at room tempera-
ture for 2 h. The slide was then washed in PBST and mounted in
Vectashield mounting media with DAPI (Vectashield Laboratories).
RNA interference
A 356 bp fragment of the plp-1 cDNA was PCR-ampliﬁed with
the primers ATGTCGGACGGAAGTGTTGA and ATGGCGATTTGTTGGC-
GAGT tagged with the T7 promoter. Double stranded RNA was
diluted 1:1 with nuclease-free water and injected into the intestine
of adult hermaphrodites. The progeny were analyzed 8–12 h after
injection. For soaking experiments, the RNA was diluted 1:1 with
50% M9 buffer containing 3 mM spermidine hydrochloride (Sigma)
and hermaphrodites were soaked for 12 h in the RNA mixture.
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